Alvotech

About:

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Website: http://www.alvotech.com

Twitter/X: alvotechpr

Top Investors: Alvogen, Athos Capital, Shinhan Capital, Aztiq, Baxter Ventures

Description:

Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to improve patients' health and quality of life around the world by increasing access to effective therapies for various ailments. Alvotech was established on January 1, 2013, by Róbert Wessman in Reykjavík, Gullbringusysla.

Total Funding Amount:

$1.72B

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Reykjavík, Gullbringusysla, Iceland

Founded Date:

2013-01-01

Contact Email:

contact-us(AT)alvotech.com

Hub Tags:

Exited Unicorn

Founders:

Róbert Wessman

Number of Employees:

501-1000

Last Funding Date:

2024-06-07

IPO Status:

Public

© 2025 bioDAO.ai